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exceeds 10%.5 Researchers have identified sever-
al system- and patient -related factors associated 
with an increased cardiovascular risk following 
a patient’s discharge from the hospital These in-
clude insufficient risk factor control, insufficient 
and delayed cardiac rehabilitation, suboptimal 
pharmacotherapy, delayed complete myocardi-
al revascularization, and comorbidities.4,10 How-
ever, the absence of cardiac consultations dur-
ing the postdischarge period is among the key 
IntroductIon The management of patients 
with acute myocardial infarction (AMI) has 
changed significantly over the last few decades, 
also in the areas of reperfusion therapy and phar-
macological treatment. This has led to a signif-
icant reduction in both short- and long -term 
mortality in most countries.1-9 However, post-
discharge mortality rates remain high. In Norway, 
for example, the 1 -year mortality rate in patients 
who survive the first 28 days after an AMI event 
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IntroductIon Mortality following acute myocardial infarction (AMI) remains high despite of progress 
in invasive and noninvasive treatments.
objEctIvEs This study aimed to compare the outcomes of ambulatory treatment provided by cardiolo‑
gists versus general practitioners (GPs) in post ‑AMI patients.
PAtIEnts And mEthods We conducted a systematic search in 3 electronic databases for interven‑
tional and observational studies that reported all ‑cause mortality, mortality from cardiovascular causes, 
stroke, and myocardial infarction at long ‑term follow ‑up following AMI. We assessed the risk of bias of 
the included studies using the Risk of Bias in Nonrandomized Studies of Interventions (ROBINS ‑I) tool. 
For randomized trials, we used the revised Cochrane risk of bias tool (RoB 2.0).
rEsuLts Two nonrandomized studies fulfilled the inclusion criteria. We assessed these studies as 
having a moderate risk of bias. We did not pool the results owing to significant heterogeneity between 
the studies. Patients consulted by both a cardiologist and a GP were at lower risk of all ‑cause death 
as compared with patients consulted by a cardiologist only (risk ratio [RR], 0.92; 95% CI, 0.85–0.99). 
Patients consulted by a cardiologist with or without GP consultation were at lower risk of all ‑cause 
death compared with those consulted by a GP only in both studies (RR, 0.8; 95% CI, 0.75–0.85 and RR, 
0.44; 95% CI, 0.41–0.47).
concLusIons Patients after AMI consulted by both a cardiologist and a GP may be at lower risk of death 
compared with patients consulted by a GP or a cardiologist only. However, these findings are based on 
moderate ‑quality nonrandomized studies. We found no evidence on the relation between the specialization 
of the physician and the risk of cardiovascular death, stroke, or myocardial infarction in AMI survivors.
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of post -AMI patients and patients with stable 
CAD, separately. If the outcomes of a study group 
were reported in more than one publication, 
we selected and included in our present anal-
ysis the publication that reported the longest 
follow -up. If a study was reported in 2 separate 
articles, we selected and included in the present 
review the article that analyzed the largest pop-
ulation. Our analysis encompassed a long time-
frame (at least 30 days after AMI).
After performing 2 calibration exercises, we 
screened titles and abstracts in 2 pairs (JP + KJ 
and DS + WS) using the Rayyan QCRI applica-
tion.16 We followed a similar procedure for full-
-text screening: after 2 calibration exercises, 
the first author of this study (JP) looked through 
all the texts in pairs with other researchers (DS, 
KJ, and WS). All the reviewers (JP, DS, KJ, and 
WS) independently collected data from primary 
studies, whereas 2 researchers (JP and DS) evalu-
ated bias using the Risk of Bias in Nonrandomized 
Studies of Interventions (ROBINS -I) tool. The col-
lected data comprised, among others, the names 
of the authors, the year and country of publica-
tion, the study purpose, elements of the PICO 
strategy, conflicts of interest, and funding. We 
resolved any discrepancies by consensus among 
the authors at every stage. In the case of miss-
ing data, we contacted the authors of the ana-
lyzed study by email. We illustrated the study 
flow at the subsequent stages of the review by 
means of the Preferred Reporting Items for Sys-
tematic Reviews and Meta -Analyses (PRISMA) 
diagram.17,18
Regarding follow -up, we looked at all -cause 
mortality, mortality from cardiovascular causes, 
stroke, and AMI. For the purposes of the present 
analysis, AMI was defined according to the defi-
nition adopted by the authors of each particular 
study. Similarly, the definition of stroke depend-
ed on the concepts used in the analyzed studies. 
A GP meant a physician working in primary care 
and included family physicians and internists. 
We defined a cardiologist as a specialist in cardi-
ology or a physician undergoing specialist train-
ing in cardiology.
We assessed the risk of bias in the studies based 
on validated tools (the revised Cochrane risk of 
bias tool [RoB 2.0] for randomized controlled 
trials and the ROBINS -I tool for nonrandom-
ized controlled trials).19,20 This information was 
incorporated and discussed within the frame-
work of qualitative data synthesis and is present-
ed in tAbLE 1.
statistical analysis In the case of nonrandom-
ized studies, data concerning the matched groups 
of patients were analyzed with the aim to reduce 
the impact of any differences in group character-
istics on the effect of the studied intervention. 
According to the protocol, random -effects sum-
mary risk ratios on the basis of the DerSimoni-
an and Laird model using 95% CIs as the measure 
of effect were used when expected heterogeneity 
factors for increased risk. For example, referring 
a patient with systolic heart failure (often after 
AMI) after discharge to a cardiologist is associated 
with a 19% reduction in 1 -year all -cause mortal-
ity (odds ratio [OR], 0.81; 95% CI, 0.68–0.95).11
The evidence regarding mortality rates in pa-
tients after AMI suggests that those treated by 
cardiologists during hospitalization are at low-
er mortality risk than patients treated by inter-
nists or general practitioners (GPs).12,13 In addi-
tion, data from the United States have shown that 
patients hospitalized for AMI and heart failure 
in areas with a low density of cardiologists were 
at a slightly higher 30 -day and 1 -year mortality 
risk.14 As a consequence, we undertook a system-
atic review of studies comparing morbidity and 
mortality in post -AMI patients treated by cardi-
ologists or primary care physicians following pa-
tients’ discharge from the hospital.
mEthods We performed an electronic search of 
the MEDLINE, EMBASE, and the Cochrane Cen-
tral Register of Controlled Trials database from its 
inception to July 4, 2019, based on a search strat-
egy specifically developed for this study. We used 
both subject headings (MeSH and EMTREE) and 
free text search terms. The following keywords 
were entered: “cardiologist” with synonyms, “gen-
eral practitioner” with synonyms and “Myocardial 
Infarction” with synonyms (for the search strate-
gy, see Supplementary material, Appendix S1). We 
did not apply any restrictions in terms of publi-
cation date or language. Our full search strategy 
was published online together with the study pro-
tocol in the PROSPERO database.15 We manually 
searched for references of the included studies, 
relevant review articles, and meta -analyses for 
any potentially overlooked studies.
We included experimental, quasi -experimental, 
and observational studies, all of which were pub-
lished as full -text articles that evaluated all -cause 
mortality and cardiovascular outcomes in post-
-AMI adult subjects (over 18 years of age) follow-
ing their discharge from the hospital. To be in-
cluded in the review, these studies had to ana-
lyze patients treated by specialists in cardiology 
(or physicians undergoing training in cardiology) 
or by physicians working in primary care (fam-
ily physicians or general internists), separately. 
Studies that did not exclude patients with stable 
coronary artery disease (CAD) were included if 
they provided information about the subgroups 
whAt’s nEw?
Our systematic search showed that patients after acute myocardial infarction 
consulted by both a cardiologist and a general practitioner may be at lower 
risk of death compared with patients consulted by a general practitioner or 
a cardiologist only. Of note, these findings are based on moderate ‑quality 
nonrandomized studies. In this study, we found no evidence on the relation 
between the specialty of the physician and the risk of cardiovascular death, 
stroke, or myocardial infarction in acute myocardial infarction survivors.
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between the studies was significantly high. Statis-
tical heterogeneity was measured using the I2 sta-
tistics.21-23 A P value less than 0.05 was considered 
significant. All the analyses were performed us-
ing the Review Manager 5.3 software.24 We per-
formed meta -analyses for each pair of treatment 
(cardiologist vs GP care) for each outcome (car-
diovascular outcomes and all -cause mortality). 
The goal was to investigate any substantial het-
erogeneity between studies.
rEsuLts A total of 4 articles25-28 met the inclu-
sion criteria. A study by Gerlach et al25 was pre-
sented only as an abstract and had to be exclud-
ed from further analysis owing to lack of suffi-
cient details. Two articles covered the same pop-
ulation within the framework of the Cooperative 
Cardiovascular Project, and a single paper26 was 
a substudy of another study,27 which was con-
firmed by the authors. As a consequence, we ex-
cluded a single substudy and included 2 studies 
in the final analysis: by Ayanian et al27 and Radzi-
manowski et al28 (FIGurE 1). We decided not to pool 
the data because of considerable heterogeneity 
between the studies (I2 = 99%), which was prob-
ably due to the significant gap between the pe-
riods of data collection (16 to 17 years), various 
methods used to treat patients after AMI dur-
ing these time periods, and different health-
care systems. We did not find any study analyz-
ing the risk of cardiovascular death, stroke, or 
myocardial infarction in patients who had a car-
diac consultation during the postdischarge pe-
riod compared with patients who did not have 
such consultation.
Both studies in our review were observational 
and included a retrospective cohort. The follow-
-up period was 1.5 years in the study conduct-
ed by Ayanian et al27 and 2 years in the study by 
Radzimanowski et al.28 The total number of pa-
tients treated by a cardiologist in the matched 
groups from both studies was 30 236. The mean 
age of patients was 69.8 years. The total number 
of patients from both groups that received no 
care from a cardiologist was also 30 236. Those pa-
tients were at a mean age of 69.8 years. The study 
populations constituting both groups were pri-
marily of male sex. In the study by Ayanian et al,27 
propensity -score matching based on sociodemo-
graphic and clinical variables was performed using 
the logistic regression model as a function of 36 
variables that predicted whether a patient would 
visit a cardiologist. In the study by Radzimanows-
ki et al,28 the matching method was similar, and 
the overall number of sociodemographic and clin-
ical variables was 26. According to Ayanian et al,27 
the most commonly reported conditions before 
admission were hypertension, angina, and diabe-
tes. In the second study,28 the most frequent com-
plications included a history of chronic ischemic 
heart disease, hypertension, and dyslipidemia.
Research elements included in the analysis ac-
cording to the PICO list and the baseline charac-
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ambulatory care from both a cardiologist and a GP 
may have better long -term outcomes than those 
treated only by a GP. To the best of our knowl-
edge, our systematic review is the first attempt to 
summarize the evidence on this topic. There are 
several reasons that could contribute to a better 
prognosis in post -AMI patients treated in outpa-
tient clinics by cardiologists in cooperation with 
GPs compared with GPs only. Perhaps, the for-
mer group has easier access to cardioprotective 
drugs in effective doses, cardiac rehabilitation, 
diagnostic workup, and some procedures, eg, re-
peat revascularizations.
The previously published systematic review de-
scribed the relationship between a physician’s spe-
cialty and the mortality of patients after AMI.12 
However, the authors of this survey considered 
only the specialization of physicians who treat-
ed patients in the hospital. It covered 11 stud-
ies. The unadjusted mortality rates were lower 
in patients treated in the acute phase by cardi-
ologists compared with those treated by physi-
cians with other specializations (eg, family phy-
sicians). After adjusting for baseline imbalances, 
shown in tAbLE 2. The studies were assessed as 
having a moderate risk of bias (tAbLE 1).
The available data allowed for 3 comparisons: 
1) patients treated by cardiologists with or with-
out GP consultation versus those treated by GPs 
only; 2) patients treated only by cardiologists 
versus those treated only by GPs; and 3) patients 
treated by both a cardiologist and a GP versus 
those treated by cardiologists only (FIGurEs 2 
and 3). The first comparison included data from 
both studies and showed a significantly lower risk 
of death in patients treated by cardiologists with 
or without care provided by GPs compared with 
those treated only by GPs. The second compari-
son could be based on a single study and showed 
no significant difference between the groups. 
The third comparison was also based on the re-
sults of a single study and showed a significant-
ly lower risk of death when patients were treat-
ed by both a cardiologist and a GP as opposed to 
those treated only by a cardiologist.
dIscussIon The results of this systematic re-
view showed that patients after AMI who received 
FIGurE 1 Summary of how the systematic search was conducted and eligible studies were identified (the PRISMA flow diagram)
Records identified through searching 

































Full‑text articles excluded (n = 28):
•  wrong study type (n = 12)
•  wrong intervention and comparator (n = 11)
•  wrong intervention (n = 1)
•  wrong comparator (n = 2)
•  wrong outcome (n = 2)
Ongoing study: not enough data, only a study 
abstract available (n = 1)
Full text not found (n = 1)
Records screened
(n = 897)
Full‑text articles assessed for eligibility
(n = 33)
2 studies in 3 publications included in 
qualitative synthesis 
(n = 3)
2 studies in 2 publications included in 
quantitative synthesis 
(n = 2)







tAbLE 2 Systematic comparison of the analyzed studies













Ayanian et al,27 2002, 
United States, CCP
(Landrum et al,26 
2001, United States, 
CCP—a substudy 




The total study group treated by cardiologists 
included 24 656 patients.
The total group treated by GPs only included 10 864 
patients.
Groups of patients matched by PSMs (comparison 1):
• Treated by cardiologists with or without GP 
consultations (n = 10 199): mean age, 74.1 yrs, 
51.9% men, 65.8% of patients with hypertension, 
33.7% with diabetes, 23.6% with IM, 53.1% with 
angina
• Treated by GPs only (n = 10 199): mean age, 
74.2 yrs, 52% men, 64.6% of patients with 
hypertension, 33.5% with diabetes, 23.4% with IM, 
52.7% with angina
Groups of patients matched by PSMs (comparison 2):
• Treated by cardiologists and GPs (n = 10 415): 
mean age, 73.2 yrs, 61.4% men, 60.9% of patients 
with hypertension, 25.9% with diabetes
• Treated by cardiologists only (n = 10 415): mean 
age, 73.2 yrs, 61.6% men, 60.6% of patients with 
hypertension, 25.4% with diabetes
Patients who were 
discharged in 
the United States 
with a principal 
diagnosis of AMI, 
at least 65 yrs with 




3 months after 
discharge
• Metastatic cancer or 












at least 1 ambulatory 
visit to a cardiologist, 
an FP, or an internist 
within 3 months after 
discharge
Patients who had 
at least 1 office visit 
with a cardiologist 
during the 3 months 
after discharge 
(with or without 
a visit to an internist 
or an FP).
Patients who 
had at least 1 
visit with a GP 
(an internist or 




3 months after 
discharge.




Radzimanowski et al,28 
2018, Germany, 
NA of SHI
RC, 2011, 158 494 
patients
The total group treated by cardiologists included 
81 030 patients.
The total group treated by GPs only included 77 464 
patients.
Groups of patients matched by PSMs (comparison 1):
• Treated by cardiologists with or without GP 
consultations (n = 20 037): mean age, 67.6 yrs, 
65.6% men, 88% of patients with hypertension, 
39.5% with diabetes, 17.8% with angina, 90.8% with 
CIHD
• Treated by GPs only (n = 20 037): mean age, 
67.6 yrs, 65.7% men, 88.2% of patients with 
hypertension, 39.3% with diabetes, 18% with 
angina, 91.3% with CIHD
Groups of patients matched by PSMs (comparison 2):
• Treated by cardiologists only (n = 982)
• Treated by GPs only (n = 982)
Patients who were 
newly diagnosed 
with AMI, coded 
as “confirmed” or 




contact in the years 
2009 to 2010
• Without ambulatory 
contact with a GP, 
an internist, or 
a cardiologist within 
the first year after 
the diagnosis of AMI
• No information about 
the type of district, 
sex, and age
Patients who were 
consulted by 
an ambulatory 
cardiologist at least 













of Statutory Health Insurance; NR, not reported; PSMs, propensity score matching methods; others, see tAbLE 1
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specialty are often influenced by relevant patient 
or resource characteristics, which were not tak-
en into account.12
The European Society of Cardiology currently 
emphasizes that low -risk patients after AMI can 
be safely discharged from the hospital 2 or 3 days 
after an effective primary percutaneous coronary 
intervention.34-36 A short hospital stay means less 
time to ensure that the patient is provided with 
the right information and receives optimal phar-
macological treatment. It is therefore becoming in-
creasingly important that a patient consults a car-
diologist shortly after hospital discharge and par-
ticipates in a formal rehabilitation program. Re-
cently, some countries have introduced managed 
care programs aimed at improving access to cardi-
ologist care following hospitalization for AMI.37,38 
For example, in Poland, the National Health Fund 
(Narodowy Fundusz Zdrowia) requires patients to 
have at least 3 consultations with a cardiologist 
within the first 12 months following AMI, with 
the first consultation within the first 6 weeks.37,39 
Managed care programs following myocardial in-
farction are highly graded by patients.40
In our view, further research should focus on 
describing the impact of the medical specialty 
the differences were often very small. The multi-
variable odds ratios for in -hospital and 30 -day 
mortality rates in patients treated by cardiologists 
versus those treated by GPs ranged from 0.95 
to 1.29,29,30 while 1 -year mortality rates ranged 
from 0.99 to 1.3.31,32 As for the lower mortality 
of patients after AMI treated by cardiologists, 
this could be due to the fact that cardiologists are 
more specialized than GPs in managing patients 
after myocardial infarction, which could lead to 
more frequent and adequate prescription of med-
ications improving survival, as well as more fre-
quent referral to cardiac rehabilitation and in-
vasive cardiology centers.33 Considering that ac-
cess to typical AMI treatment (both percutane-
ous coronary intervention and medical therapy) 
is nowadays granted, the effect of physician spe-
cialty may be lower.
Hartz et al12 underlined the fact that no stud-
ies adequately accounted for reasons why a cardi-
ologist did not treat patients who had sustained 
myocardial infarction. These reasons might in-
clude, for example, patient preferences, aggra-
vation of comorbidities, general health status, 
or resource availability.12 Moreover, results com-
paring patient outcomes by treating physician’s 
FIGurE 2 Risk ratios of all ‑cause mortality for the comparison of patients treated by cardiologists with or without general practitioner consultations 
versus treated by general practitioners only, the comparison of patients treated by cardiologists only versus treated by general practitioners only, and 
the comparison of patients treated by cardiologists and general practitioners versus treated by cardiologists only 
Abbreviations: M–H, Mantel–Haenszel method; others, see tAbLE 1
Cardiologist with or without GP vs GP only
Radzimanowski et al28          1184       20 037      2716   20 037           0.44 (0.41–0.47)
Ayanian et al27                      1489      10 199      1866    10 199           0.80 (0.75–0.85)
Cardiologist only vs GP only
Radzimanowski et al28           118         982         128       982              0.92 (0.73–1.16)
Cardiologist and GP vs cardiologist only
Ayanian et al27                      1156      10 415      1260    10 415           0.92 (0.85–0.99)
Cardiologist             Control                       Risk ratio                                                Risk ratio
Study or subgroup              Events       Total     Events    Total       M–H, Random, 95% Cl                            M–H, Random, 95% Cl
0.5 0.7 1 1.5 2
Favors (intervention)                Favors (control)
FIGurE 3 Risk difference of all ‑cause mortality for the comparison of patients treated by cardiologists with or without general practitioner 
consultations versus treated by general practitioners only, the comparison of patients treated by cardiologists only versus treated by general 
practitioners only, and the comparison of patients treated by cardiologists and general practitioners versus treated by cardiologists only 
Abbreviations: see FIGurE 2 and tAbLE 1
Cardiologist with or without GP vs GP only
Radzimanowski et al28         1184       20 037      2716   20 037        –0.08 (–0.08 to –0.07)
Ayanian et al27                     1489       10 199      1866   10 199         –0.04 (–0.05 to –0.03)
Cardiologist only vs GP only
Radzimanowski et al28          118          982         128       982           –0.01 (–0.04 to 0.02)
Cardiologist and GP vs cardiologist only
Ayanian et al27                     1156      10 415      1260    10 415        –0.01 (–0.02 to 0)
Cardiologist            Control                   Risk difference                                       Risk difference
Study or subgroup              Events     Total      Events    Total        M–H, Random, 95% Cl                            M–H, Random, 95% Cl
–0.05 –0.025 0 0.025 0.05
Favors (intervention)        Favors (control)
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on the mortality of patients after AMI, especial-
ly from the perspective of providing more effec-
tively defined interventions (number and dura-
tion of visits in a given period of time).
Limitations The present systematic review had 
several limitations. First, the studies were obser-
vational and nonrandomized. No single double-
-blinded study fulfilled the inclusion criteria. Sec-
ond, only 2 studies were included in the review. 
Despite extensive database search, we found only 
these studies and this may result in publication 
bias. It is important to note that one of these 
studies contained the data of patients hospital-
ized from 1994 to 1995, whereas the other study 
included a considerable amount of recent data. 
Therefore, their results may not reflect the cur-
rent practice.27,28 Over the years, the treatment 
of patients with AMI both during hospitalization 
and in the postdischarge period has significantly 
changed. Invasive treatment in the acute phase 
of AMI has spread, thrombolysis has become less 
common, numerous new drugs have been intro-
duced in routine clinical practice, eg, clopidogrel, 
ticagrelor, statins, and renin–angiotensin–aldo-
sterone system inhibitors. This could have caused 
significant heterogeneity between the studies we 
have found. Finally, the fact that the first study 
was performed in the United States and the other 
in Germany is also a limitation, as these countries 
have diverse health and healthcare professional 
education systems, which results in discrepancies 
in competencies and referral for procedures.41,42
conclusions This systematic review suggested 
that patients after AMI who were consulted by 
both a cardiologist and a GP may be at lower risk 
of death compared with those consulted by a GP 
or a cardiologist alone, although we found no 
high-quality, up -to -date analyses in this field. 
We found no evidence regarding the relationship 
between the specialization of a physician and 
the risk of patients’ cardiovascular death, stroke, 
or myocardial infarction in AMI survivors. There 
is an urgent need for new, properly reported re-
search in this area. These studies should focus 
not only on all -cause mortality, but also on recur-
rent AMI, stroke, and cardiovascular mortality.
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